DIP2C-AS1

Across TCGA pan-cancer cohorts, DIP2C-AS1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated DIP2C-AS1 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher DIP2C-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DIP2C-AS1 expression acts as an unfavorable survival marker.

COAD, BRCA, and CESC are the cancer types where DIP2C-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.133	0.806	<.001	27	view →
BRCA	DFS	Median	All	0.230	0.903	<.001	18	view →
CESC	OS	Median	All	0.261	0.798	.006	12	view →
SARC	DFS	Median	All	0.121	0.611	.041	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

DIP2C-AS1–COAD (OS)

Open the COAD breakdown →